Company
Aradigm
Also known as Aradigm, Inc
- Business model
- B2B
- Legal name
- Aradigm, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Funding snapshot
- Total raised
- $27.1MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $23M2016-04-25
Funding rounds
- Round, 2016
- $23M2016-04-25, SEC form D sold, 5 investors
- Round, 2010
- $4.1M2010-06-21, SEC form D sold, 9 investors
Loading relationship preview